|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07J 7/00 | |
| A61K 31/568 | |||
| A61K 31/5685 | |||
| A61K 31/57 | |||
| A61P 25/00 | |||
| A61P 25/10 | |||
| A61P 25/28 | |||
| C07J 1/00 | |||
| C07J 41/00 |
| (11) | Patento numeris | 2711371 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13198584.8 |
| Europos patento paraiškos padavimo data | 2007-11-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-03-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 860658 P | 2006-11-21 | US |
| (72) |
Bäckström, Torbjörn, SE
Ragagnin, Gianna, SE
|
| (73) |
Asarina Pharma AB,
Karolinska Institutet Science Park Fogdevreten 2, 171 65 Solna,
SE
|
| (54) | The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders |
| The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders |